Glyburide-d3

For research use only. Not for therapeutic Use.

  • CAT Number: S000135
  • CAS Number: 1219803-02-7
  • Molecular Formula: C23H25D3ClN3O5S
  • Molecular Weight: 497.02
  • Purity: ≥95%
Inquiry Now

Glyburide-d3 (CAS: 1219803-02-7), a premium pharmaceutical research compound designed for advanced studies in diabetes and metabolic research. As a deuterated analog of Glyburide, it offers enhanced stability and improved pharmacokinetic properties. Glyburide-d3 is ideal for use in pharmacological and biochemical research, providing precise and reliable data for your studies. This high-purity compound ensures consistent results, aiding in the development of novel therapies for diabetes management. Trusted by leading laboratories, Glyburide-d3 is your go-to solution for cutting-edge diabetes research. Unlock new possibilities in diabetes treatment with Glyburide-d3, where innovation meets reliability.


Catalog Number S000135
CAS Number 1219803-02-7
Molecular Formula C23H25D3ClN3O5S
Purity ≥95%
Target Autophagy
IUPAC Name 5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-(trideuteriomethoxy)benzamide
InChI InChI=1S/C23H28ClN3O5S/c1-32-21-12-9-17(24)15-20(21)22(28)25-14-13-16-7-10-19(11-8-16)33(30,31)27-23(29)26-18-5-3-2-4-6-18/h7-12,15,18H,2-6,13-14H2,1H3,(H,25,28)(H2,26,27,29)/i1D3
InChIKey ZNNLBTZKUZBEKO-FIBGUPNXSA-N
SMILES [2H]C([2H])([2H])OC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
Reference

[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.
[Content Brief]

[2]. Heo R, et al. The anti-diabetic drug trelagliptin induces vasodilation via activation of Kv channels and SERCA pumps. Life Sci. 2021;283:119868.
[Content Brief]

[3]. Qiu Y, et al. Glyburide Regulates UCP1 Expression in Adipocytes Independent of KATP Channel Blockade. iScience. 2020;23(9):101446.
[Content Brief]

[4]. Golstein PE, et al. P-glycoprotein inhibition by glibenclamide and related compounds. Pflugers Arch. 1999;437(5):652-660.
[Content Brief]

[5]. Fernandes MA, et al. Glibenclamide interferes with mitochondrial bioenergetics by inducing changes on membrane ion permeability. J Biochem Mol Toxicol. 2004;18(3):162-169.
[Content Brief]

[6]. Zhou J, et al. Glibenclamide-Induced Autophagy Inhibits Its Insulin Secretion-Improving Function in β Cells. Int J Endocrinol. 2019;2019:1265175.
[Content Brief]

Request a Quote